| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5913358 | Blood Cells, Molecules, and Diseases | 2016 | 5 Pages |
Abstract
Lymphopenia, the decreased absolute number of T cells, Tregs, and a percentage of apoptotic cells, correlates with clinical staging in DLBCL patients. The increased number of B cells and the decreased level of Tregs and apoptotic cells after treatment might predict a poor clinical outcome in patients treated with RCHOP. Thereby, flow-cytometry-based evaluation of peripheral blood lymphocytes may be useful in prognostication of newly diagnosed DLBCL patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
MaÅgorzata Rusak, Åukasz BoÅkun, Joanna Chociej-StypuÅkowska, Joanna Pawlus, Janusz KÅoczko, Milena DÄ
browska,